Chemotherapy vs. Immunotherapy in combating nCOVID19: An update

A Choudhury, G Mukherjee, S Mukherjee - Human Immunology, 2021 - Elsevier
The nCOVID-19 pandemic initiated its course of contagion from the city of Wuhan and now it
has spread all over the globe. SARS-CoV-2 is the causative virus and the infection as well …

Host-based treatments for severe COVID-19

L Mondini, F Salton, L Trotta, C Bozzi… - Current Issues in …, 2023 - mdpi.com
COVID-19 has been a global health problem since 2020. There are different spectrums of
manifestation of this disease, ranging from asymptomatic to extremely severe forms …

Cytokine storm induced by SARS-CoV-2

P Song, W Li, J Xie, Y Hou, C You - Clinica chimica acta, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by the virus designated as severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread widely throughout the …

[PDF][PDF] Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2

IF Chukwuma, VO Apeh, OF Chiletugo - Acta Virol, 2021 - researchgate.net
Coronavirus infection is now the leading cause of death globally. Despite the several
bedsides-to-bench investigations carried out by researchers all over the world to identify the …

COVID-19, SARS-CoV-2, origin, transmission and treatment aspects, a brief review

S Nawaz - Infectious Disorders-Drug Targets (Formerly Current …, 2021 - ingentaconnect.com
The emergence of Severe Acute Respiratory Syndrome (SARS) in named as corona virus
disease 19 (covid-19) caused by the novel corona virus SARS-CoV-2 has caused hundreds …

Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents

S Khadke, N Ahmed, N Ahmed, R Ratts, S Raju… - Virology journal, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is caused by Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, previously named 2019-nCov), a novel …

Pathogenesis, diagnosis and possible therapeutic options for COVID-19

MA Ullah, Y Araf, B Sarkar, AT Moin, RAI Reshad… - 2020 - preprints.org
The recent pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has spread so rapidly and severely affected the people of almost every country in the …

Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective

YK Ratre, N Kahar, L Bhaskar, A Bhattacharya… - 3 Biotech, 2021 - Springer
Abstract Novel coronavirus disease 2019 (COVID-19) is a positive-sense single-stranded
RNA virus which belongs to the Coronaviridae family. COVID-19 outbreak became evident …

Road map to understanding SARS-CoV-2 clinico-immunopathology and COVID-19 disease severity

D Karmakar, B Lahiri, P Ranjan, J Chatterjee, P Lahiri… - Pathogens, 2020 - mdpi.com
SARS-CoV-2, a novel coronavirus, was first identified in Wuhan, China in December 2019.
The rapid spread of the virus worldwide prompted the World Health Organization (WHO) to …

SARS‐CoV‐2: Mechanism of infection and emerging technologies for future prospects

S Li, S Li, C Disoma, R Zheng, M Zhou… - Reviews in Medical …, 2021 - Wiley Online Library
The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
spread globally to over 200 countries with more than 23 million confirmed cases and at least …